NCT00219024View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

PHASE3CompletedINTERVENTIONAL
Enrollment

2,775

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Hypertension
Interventions
DRUG

aliskiren

Trial Locations (2)

Unknown

Novartis Pharmaceuticals, East Hanover

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00219024 - Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension. | Biotech Hunter | Biotech Hunter